TD Cowen raises Mondelez stock price target on strong earnings By Investing.com

TD Cowen raised Mondelez’s price target to $67 from $65 and lifted its 2026 EPS estimate to $3.09, citing improved European retail negotiations, emerging-market momentum, and stronger U.S. execution. Mondelez also beat Q1 expectations with EPS of $0.67 versus $0.61 consensus and revenue of $10.08 billion, while maintaining a 3.42% dividend yield and 12 straight years of dividend growth. The 2027 EPS estimate was trimmed to $3.42 as management plans to reinvest cocoa-deflation savings.

Analysis

MDLZ is benefiting from a classic quality-growth rerating setup: resilient unit economics, visible dividend support, and a valuation that can keep expanding as long as pricing and mix offset commodity reinvestment. The real second-order effect is not the beat itself, but the signal that global snack demand remains elastic enough to absorb price/mix actions without a meaningful volume air pocket, which should help defensive staples multiples more broadly. That said, the market may be underestimating how much of the near-term estimate lift is already tied to favorable input-cost dynamics rather than durable operating leverage.

The main risk is that cocoa relief becomes a trap for earnings quality. If management chooses to redeploy savings into promo, distribution, or market share defense, 2027 earnings power can lag visible revenue growth, limiting multiple expansion and creating a “good quarter, flat stock” outcome over the next 6-12 months. Emerging markets are the cleanest incremental upside lever, but they also carry the most currency and affordability sensitivity, so any dollar strength or consumer pullback would hit the bull case first.

Consensus looks mildly too optimistic on the persistence of margin normalization. The market appears to be pricing a smooth glide path for 2026-27 estimates, but staple names with premium valuation usually de-rate quickly when investors detect that incremental gross margin is being reinvested rather than monetized. The better trade is to own the relative quality of MDLZ versus lower-duration consumer names, not to chase an outright multiple expansion story from here.

Key Decisions for Investors

• Stay long MDLZ, but add only on pullbacks over the next 2-4 weeks; use the stock as a defensives-quality anchor with a 12-month risk/reward skewed to mid-single-digit upside plus yield, but limited near-term catalyst risk if guidance emphasizes reinvestment.
• Pair trade: long MDLZ / short a lower-quality packaged food peer with weaker margin visibility and less pricing power over the next 1-3 months; this isolates durable brand equity and dividend support while avoiding sector beta.
• Consider selling upside calls against a long MDLZ position into strength for the next earnings cycle; the setup looks more like steady compounding than a re-rating breakout, so call overwrite can harvest elevated implied optimism.
• If cocoa-related margin tailwinds continue into the next quarter, take profits on 25-33% of any tactical long because the market may have already capitalized much of the near-term benefit before 2027 reinvestment becomes the focus.